GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Tactile Systems Technology Inc (NAS:TCMD) » Definitions » Sloan Ratio %

Tactile Systems Technology (Tactile Systems Technology) Sloan Ratio % : -2.35% (As of Mar. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Tactile Systems Technology Sloan Ratio %?

Richard Sloan from the University of Michigan was first to document what is referred to as the "accrual anomaly". His 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones.

Tactile Systems Technology's Sloan Ratio for the quarter that ended in Mar. 2024 was -2.35%.

As of Mar. 2024, Tactile Systems Technology has a Sloan Ratio of -2.35%, indicating the company is in the safe zone and there is no funny business with accruals.


Tactile Systems Technology Sloan Ratio % Historical Data

The historical data trend for Tactile Systems Technology's Sloan Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tactile Systems Technology Sloan Ratio % Chart

Tactile Systems Technology Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Sloan Ratio %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.11 -13.55 27.73 -8.30 -1.73

Tactile Systems Technology Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Sloan Ratio % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.66 -6.04 1.77 -1.73 -2.35

Competitive Comparison of Tactile Systems Technology's Sloan Ratio %

For the Medical Devices subindustry, Tactile Systems Technology's Sloan Ratio %, along with its competitors' market caps and Sloan Ratio % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tactile Systems Technology's Sloan Ratio % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Tactile Systems Technology's Sloan Ratio % distribution charts can be found below:

* The bar in red indicates where Tactile Systems Technology's Sloan Ratio % falls into.



Tactile Systems Technology Sloan Ratio % Calculation

Earnings contain a lot of non cash earnings which is called accruals. The Sloan ratio is a way to identify firms with low non-cash or accrual-derived earnings relative to their cash flow.

Tactile Systems Technology's Sloan Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Sloan Ratio=(Net Income (A: Dec. 2023 )-Cash Flow from Operations (A: Dec. 2023 )
-Cash Flow from Investing (A: Dec. 2023 ))/Total Assets (A: Dec. 2023 )
=(28.515-35.855
--2.481)/281.438
=-1.73%

Tactile Systems Technology's Sloan Ratio for the quarter that ended in Mar. 2024 is calculated as

Sloan Ratio=(Net Income (TTM)-Cash Flow from Operations (TTM))
-Cash Flow from Investing (TTM))/Total Assets (Q: Mar. 2024 )
=(28.192-37.281
--2.692)/272.04
=-2.35%

Tactile Systems Technology's Net Income for the trailing twelve months (TTM) ended in Mar. 2024 was -0.1 (Jun. 2023 ) + 22.299 (Sep. 2023 ) + 8.202 (Dec. 2023 ) + -2.209 (Mar. 2024 ) = $28.2 Mil.
Tactile Systems Technology's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2024 was 13.909 (Jun. 2023 ) + 4.096 (Sep. 2023 ) + 18.352 (Dec. 2023 ) + 0.924 (Mar. 2024 ) = $37.3 Mil.
Tactile Systems Technology's Cash Flow from Investing for the trailing twelve months (TTM) ended in Mar. 2024 was -0.851 (Jun. 2023 ) + -0.399 (Sep. 2023 ) + -0.94 (Dec. 2023 ) + -0.502 (Mar. 2024 ) = $-2.7 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Tactile Systems Technology  (NAS:TCMD) Sloan Ratio % Explanation

A former University of Michigan researcher, Richard Sloan's 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones. In fact, for the 40-year period between 1962 and 2001, buying the lowest accrual companies and shorting the highest accrual companies resulted in an average annual compounded return of 18%, more than double the S&P 500's 7.4% annual return over the same period.

According to How to Beat the Market with the Sloan Ratio:

If the Sloan Ratio is between -10% and 10%, the company is in the safe zone and there is no funny business with accruals.

If the Sloan Ratio is less than between -25% and -10% on the negative side, and between 10% and 25% on the positive side, this is a warning stage of accrual build up.

If the Sloan Ratio is less than -25% or greater than 25%, and this ratio is consistent over several quarters or even years, be careful. Earnings are highly likely to be made up of accruals.

As of Mar. 2024, Tactile Systems Technology has a Sloan Ratio of -2.35%, indicating the company is in the safe zone and there is no funny business with accruals.


Tactile Systems Technology Sloan Ratio % Related Terms

Thank you for viewing the detailed overview of Tactile Systems Technology's Sloan Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.


Tactile Systems Technology (Tactile Systems Technology) Business Description

Traded in Other Exchanges
Address
3701 Wayzata Boulevard, Suite 300, Minneapolis, MN, USA, 55416
Tactile Systems Technology Inc is a medical technology company. The company is engaged in developing and providing medical devices for the treatment of chronic diseases. The firm's proprietary platform flexitouch system provides a home-based solution for lymphedema patients. The entire system is another home solution for patients with chronic swelling and actitouch system for chronic venous insufficiency patients that may be worn throughout the day.
Executives
Boyd Vindell Washington director 1331 TYLER STREET NE, STE 200, MINNEAPOLIS MN 55413
Daniel L. Reuvers director, officer: President and CEO INTEGRA LIFESCIENCES CORPORATION, 311 ENTERPRISE DRIVE, PLAINSBORO NJ 08536
Sherri Lee Ferstler officer: Senior VP, Sales 1331 TYLER STREET NE, STE 200, MINNEAPOLIS MN 55413
William W Burke director 3868 MOCKINGBIRD LN, DALLAS TX 75205
Kristie Burns officer: Sr. VP Mktg & Clinical Affairs 3701 WAYZATA BLVD, MINNEAPOLIS MN 55416
Eric Pauls officer: Senior VP, Sales 3701 WAYZATA BLVD, SUITE 300, MINNEAPOLIS MN 55416
Elaine M. Birkemeyer officer: Chief Financial Officer 3701 WAYZATA BLVD, SUITE 300, MINNEAPOLIS MN 55416
Brent Moen officer: Chief Financial Officer 3600 HOLLY LANE NORTH, SUITE 40, PLYMOUTH MN 55447
Carmen B Volkart director C/O MODULAR MEDICAL, INC., 16772 WEST BERNARDO DRIVE, SAN DIEGO CA 92127
Valerie L. Asbury director 3701 WAYZATA BLVD, SUITE 300, MINNEAPOLIS MN 55416
David Brent Shafer director 2800 ROCKCREEK PARKWAY, NORTH KANSAS CITY MO 64117
Bryan Rishe officer: Vice President, Sales 1331 TYLER STREET NE, SUITE 200, MINNEAPOLIS MN 55413
Deepti Jain director 3701 WAYZATA BLVD, MINNEAPOLIS MN 55416
Sheri Louise Dodd director 3701 WAYZATA BLVD, SUITE 300, MINNEAPOLIS MN 55416
Gerald R. Mattys director, officer: Chief Executive Officer 1331 TYLER STREET NE, SUITE 200, MINNEAPOLIS MN 55413